Expression and polarized localization of the hemochromatosis gene product HFE in retinal pigment epithelium

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 10, 2006, Pages 4238-4244

  Martin, Pamela M ^a   Gnana Prakasam, Jaya P ^a   Roon, Penny ^a   Smith, Robert G ^a   Smith, Sylvia B ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD71 ANTIGEN; GENE PRODUCT; HFE PROTEIN; MESSENGER RNA; TRANSFERRIN RECEPTOR 2; HFE PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; TFRC PROTEIN, MOUSE; TRANSFERRIN RECEPTOR; TRFR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BAGG ALBINO MOUSE; BASOLATERAL MEMBRANE; C57BL 6 MOUSE; CONTROLLED STUDY; GENE; GENE MUTATION; HEMOCHROMATOSIS; HFE GENE; IMMUNOFLUORESCENCE; IMMUNOGOLD ELECTRON MICROSCOPY; IN SITU HYBRIDIZATION; IRON METABOLISM; IRON OVERLOAD; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RETINA; RETINA DEGENERATION; RETINA DISEASE; RETINA NEUROEPITHELIAL LAYER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BASEMENT MEMBRANE; C57BL MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOELECTRON MICROSCOPY; METABOLISM; PHYSIOLOGY;

ANIMALS; BASEMENT MEMBRANE; BETA 2-MICROGLOBULIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IN SITU HYBRIDIZATION; IRON; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; PIGMENT EPITHELIUM OF EYE; RECEPTORS, TRANSFERRIN; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750580276     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0026     Document Type: Article

References (39)

1. Donovan A, Andrews NC. The molecular regulation of iron metabolism. Hematol J. 2004;5:373-380.
2. Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathophysiology of hereditary hemochromatosis. Semin Liver Dis. 2005;25:411-419.
3. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med. 2006;57:331-347.
4. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol. 2006;290:G199-G203.
5. Fleming RE, Britton RS. Iron imports. VI. HFE and regulation of intestinal iron absorption. Am J Physiol. 2006;290:G590-G594.
6. Pietrangelo A. Non-HFE hemochromatosis. Semin Liver Dis. 2005;25:450-460.
7. Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr Gastroenterol Rep. 2004;6:44-51.
8. Hahn P, Qian Y, Dentchev T, et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 2004;101:13850-13855.
9. c by human immunodeficiency virus type 1 transactivator protein Tat in the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2004;45:2906-2914.
10. Bridges CD, Kekuda R, Huang W, et al. Expression and differential polarization of the reduced-folate transporter-1 and folate receptor-α in mammalian retinal pigment epithelium. J Biol Chem. 2000;275:20676-20684.
11. Rajan DP, Kekuda R, Chancy CD, Huang W, Ganapathy V, Smith SB. Expression of the extraneuronal monoamine transporter in RPE and neural retina. Curr Eye Res. 2000;20:195-204.
12. Ola SM, Moore P, Maddox D, et al. Analysis of sigma receptor (sigmaR1) expression in the retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res. 2002;107:97-107.
13. Philp NJ, Wang D, Yoon H, Hjelmeland LM. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest Ophthalmol Vis Sci. 2003;44;1716-1721.
14. Deora AA, Philp NJ, Hu J, Bok D, Rodriguez-Boulan E. Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. Proc Natl Acad Sci USA. 2005;102:16245-16250.
15. Horisberger M, Rosset J. Colloidal gold, a useful marker for transmission and scanning electron microscopy. J Histochem Cytochem. 1977;25:295-305.
16. Sugasawa K, Deguchi J, Okami T, et al. Immunocytochemical analyses of distributions of Na, K-ATPase and GLUT1, insulin and transferrin receptors in the developing retinal pigment epithelial cells. Cell Struct Funct 1994;19:21-28.
17. Yefimova MG, Jeanny JC, Guillonneau X, et al. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest Ophthalmol Vis Sci. 2000;41:2343-2351.
18. Yefimova MG, Jeanny JC, Keller N, et al. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 2002;43:537-545.
19. Griffiths WJH, Cox TM. Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. J Histochem Cytochem. 2003;51:613-623.
20. Hahn P, Dentchev T, Qian Y, Rouault T, Harris ZL, Dunaief JL. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol Vis. 2004;10:598-607.
21. Bok D. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci. 1993;17:189-195.
22. McKie AT, Barlow DJ. The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1) Pflugers Arch. 447:801-806, 2004.
23. Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol 2002;39:282-289.
24. Anderson GJ, Frazer DM, McKie AT, Vulpe CD. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol Dis. 2002;29:367-375.
25. Wang ZJ, Lam KW, Lam TT, Tso MO. Iron-induced apoptosis in the photoreceptor cells of rats. Invest Ophthalmol Vis Sci. 1998;39:631-633.
26. Hahn P, Milam AH, Dunaief JL. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol. 2003;121:1099-1105.
27. Dentchev T, Hahn P, Dunaief JL. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol. 2005;123:1745-1746.
28. Davies G, Dymock I, Harry J, Williams R. Deposition of melanin and iron in ocular structures in haemochromatosis. Br J Ophthalmol. 1972;56:338-342.
29. Roth AM, Foos RY. Ocular pathologic changes in primary hemochromatosis. Arch Ophthalmol. 1972;87:507-514.
30. Neumann MA. Hemochromatosis of the central nervous system. J Neuropathol Exp Neurol. 1948;7:19-34.
31. McDougal DB, Adams RD. The neuropathological changes in haemochromatosis. J Neuropathol Exp Neurol. 1950;9:117-118.
32. Miyasaki K, Murao S, Koizumi N. Hemochromatosis associated with brain lesions: a disorder of trace-metal binding proteins and/or polymers. J Neuropathol Exp Neurol. 1977;36:964-976.
33. Nielsen JE, Jensen LN, Krabbe K. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J Neurol Neurosurg Psychiatry. 1995;59:318-321.
34. Berg D, Hoggenmuller U, Hofmann E, et al. The basal ganglia in haemochromatosis. Neuroradiology. 2000;42:9-13.
35. Costello DJ, Walsh SL, Harrington HJ, Walsh CH. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry. 2004;75:631-633.
36. Dekker MC, Giesbergen PC, Njajou OT, et al. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett. 2003;348:117-119.
37. Pulliam JF, Jennings CD, Kryscio RJ, et al. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am J Med Genet. 2003;119:48-53.
38. Connor JR, Milward EA, Moalem S, et al. Is hemochromatosis a risk factor for Alzheimer's disease? J Alzheimers Dis. 2001;3:471-477.
39. Wang XS, Lee S, Simmons Z, et al Increased incidence of the HFE mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci. 2004;227:27-33.